Adeel Ahmed-Daudpota
Director Ejecutivo en IMMUNE PHARMACEUTICALS, INC. .
Cargos activos de Adeel Ahmed-Daudpota
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Director Ejecutivo | 12/04/2021 | - |
Presidente | 12/04/2021 | - |
Historial de carrera de Adeel Ahmed-Daudpota
Estadísticas
Internacional
Estados Unidos | 2 |
Operativa
Chief Executive Officer | 1 |
President | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Adeel Ahmed-Daudpota
- Experiencia